questionsmedicales.fr
Cellules
Neurones
Neurofibres myélinisées
Neurofibres myélinisées : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Neuropathie
Électromyographie
Imagerie par résonance magnétique
Myéline
Symptômes neurologiques
Douleur
Tests génétiques
Neuropathies héréditaires
Antécédents médicaux
Facteurs de risque
Symptômes
5
Neuropathie
Symptômes neurologiques
Évolution des symptômes
Neuropathie
Prévention
5
Prévention
Maladies chroniques
Prévention des blessures
Traumatismes
Traitements
5
Traitement
Physiothérapie
Analgésiques
Anticonvulsivants
Physiothérapie
Réhabilitation
Médecine alternative
Acupuncture
Médecine personnalisée
Traitement
Complications
5
Complications
Douleurs chroniques
Gestion des complications
Équipe multidisciplinaire
Facteurs de risque
5
Facteurs de risque
Diabète
Hérédité
Neuropathies héréditaires
Vieillissement
Neuropathie
Maladies auto-immunes
Sclérose en plaques
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Neurofibres myélinisées : Questions médicales les plus fréquentes",
"headline": "Neurofibres myélinisées : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Neurofibres myélinisées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-09",
"dateModified": "2025-05-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Neurofibres myélinisées"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Neurones",
"url": "https://questionsmedicales.fr/mesh/D009474",
"about": {
"@type": "MedicalCondition",
"name": "Neurones",
"code": {
"@type": "MedicalCode",
"code": "D009474",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A11.671"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Neurofibres myélinisées",
"alternateName": "Nerve Fibers, Myelinated",
"code": {
"@type": "MedicalCode",
"code": "D009413",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "S E Avetisov",
"url": "https://questionsmedicales.fr/author/S%20E%20Avetisov",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Z V Surnina",
"url": "https://questionsmedicales.fr/author/Z%20V%20Surnina",
"affiliation": {
"@type": "Organization",
"name": "Krasnov Research Institute of Eye Diseases, Moscow, Russia."
}
},
{
"@type": "Person",
"name": "Yang Shen",
"url": "https://questionsmedicales.fr/author/Yang%20Shen",
"affiliation": {
"@type": "Organization",
"name": "Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Xingtao Zhou",
"url": "https://questionsmedicales.fr/author/Xingtao%20Zhou",
"affiliation": {
"@type": "Organization",
"name": "Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Markus Axer",
"url": "https://questionsmedicales.fr/author/Markus%20Axer",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identifying geographic atrophy.",
"datePublished": "2023-03-17",
"url": "https://questionsmedicales.fr/article/36943458",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/ICU.0000000000000952"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantification of Vocal Fold Atrophy in Age-Related and Parkinson's Disease-Related Vocal Atrophy.",
"datePublished": "2022-09-16",
"url": "https://questionsmedicales.fr/article/36111826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/lary.30394"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sequential treatment in vulvovaginal atrophy.",
"datePublished": "2023-04-27",
"url": "https://questionsmedicales.fr/article/37105219",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/13697137.2023.2197588"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantitative multimodal imaging of extensive macular atrophy with pseudodrusen and geographic atrophy with diffuse trickling pattern.",
"datePublished": "2023-02-01",
"url": "https://questionsmedicales.fr/article/36725879",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-28906-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dentatorubropallidoluysian Atrophy with Prominent Autonomic Dysfunction.",
"datePublished": "2022-08-20",
"url": "https://questionsmedicales.fr/article/35989279",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2169/internalmedicine.9616-22"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Cellules",
"item": "https://questionsmedicales.fr/mesh/D002477"
},
{
"@type": "ListItem",
"position": 3,
"name": "Neurones",
"item": "https://questionsmedicales.fr/mesh/D009474"
},
{
"@type": "ListItem",
"position": 4,
"name": "Neurofibres myélinisées",
"item": "https://questionsmedicales.fr/mesh/D009413"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Neurofibres myélinisées - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Neurofibres myélinisées",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-15",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Neurofibres myélinisées",
"description": "Comment diagnostiquer une neuropathie myélinisée ?\nQuels tests d'imagerie sont utilisés ?\nQuels signes cliniques indiquent une atteinte myélinisée ?\nPeut-on détecter des anomalies génétiques ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Atrophy#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Neurofibres myélinisées",
"description": "Quels sont les symptômes courants des neuropathies myélinisées ?\nLes symptômes varient-ils selon l'âge ?\nComment les symptômes évoluent-ils ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes affectent-ils la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Atrophy#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Neurofibres myélinisées",
"description": "Peut-on prévenir les neuropathies myélinisées ?\nQuel rôle joue le mode de vie dans la prévention ?\nLes vaccinations peuvent-elles aider ?\nComment éviter les blessures nerveuses ?\nLe stress a-t-il un impact sur la santé nerveuse ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Atrophy#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Neurofibres myélinisées",
"description": "Quels traitements sont disponibles pour les neuropathies myélinisées ?\nLes médicaments peuvent-ils soulager la douleur ?\nLa physiothérapie est-elle bénéfique ?\nY a-t-il des traitements alternatifs ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Atrophy#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Neurofibres myélinisées",
"description": "Quelles complications peuvent survenir ?\nLes neuropathies peuvent-elles entraîner des handicaps ?\nY a-t-il un risque accru de chutes ?\nLes complications peuvent-elles affecter la santé mentale ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Atrophy#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Neurofibres myélinisées",
"description": "Quels sont les principaux facteurs de risque ?\nL'hérédité joue-t-elle un rôle ?\nLe vieillissement est-il un facteur de risque ?\nLes maladies auto-immunes sont-elles un risque ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D009413?mesh_terms=Atrophy#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une neuropathie myélinisée ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un électromyogramme (EMG) et des études de conduction nerveuse sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'IRM peut aider à visualiser les lésions nerveuses et la myéline."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une atteinte myélinisée ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des engourdissements, des faiblesses ou des douleurs peuvent indiquer cela."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies génétiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations liées à des neuropathies."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier des maladies sous-jacentes ou des facteurs de risque."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des neuropathies myélinisées ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Engourdissements, picotements, douleurs, faiblesse musculaire et réflexes diminués."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent être plus prononcés chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent s'aggraver progressivement ou apparaître par poussées selon la cause."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs intenses ou une perte de fonction soudaine nécessitent une attention médicale."
}
},
{
"@type": "Question",
"name": "Les symptômes affectent-ils la qualité de vie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent limiter les activités quotidiennes et affecter le bien-être général."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les neuropathies myélinisées ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines neuropathies peuvent être évitées en contrôlant les maladies sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quel rôle joue le mode de vie dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée et de l'exercice, est crucial."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles aider ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines vaccinations préviennent des infections pouvant causer des neuropathies."
}
},
{
"@type": "Question",
"name": "Comment éviter les blessures nerveuses ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les positions prolongées et les traumatismes peut réduire le risque."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur la santé nerveuse ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut aggraver les symptômes nerveux et affecter la santé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les neuropathies myélinisées ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la médication, la physiothérapie et parfois la chirurgie."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils soulager la douleur ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des analgésiques et des anticonvulsivants sont souvent prescrits."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle bénéfique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à améliorer la force musculaire et la coordination."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des approches comme l'acupuncture peuvent être envisagées, mais avec prudence."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont adaptés selon la cause et la gravité des symptômes."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent la perte de fonction, des douleurs chroniques et des infections."
}
},
{
"@type": "Question",
"name": "Les neuropathies peuvent-elles entraîner des handicaps ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des neuropathies sévères peuvent entraîner des handicaps fonctionnels significatifs."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de chutes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la faiblesse musculaire et les troubles de l'équilibre augmentent le risque de chutes."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles affecter la santé mentale ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur chronique et la perte de fonction peuvent mener à l'anxiété et à la dépression."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une approche multidisciplinaire incluant médecins, physiothérapeutes et psychologues est essentielle."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète, l'alcoolisme, les infections et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "L'hérédité joue-t-elle un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines neuropathies sont héréditaires et peuvent être transmises dans les familles."
}
},
{
"@type": "Question",
"name": "Le vieillissement est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement augmente le risque de développer des neuropathies myélinisées."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes sont-elles un risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques augmentent le risque de neuropathies."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/05/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Sechenov First Moscow State Medical University, Moscow, Russia.
Publications dans "Neurofibres myélinisées" :
3 publications dans cette catégorie
Affiliations :
Krasnov Research Institute of Eye Diseases, Moscow, Russia.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Eye Institute and Department of Ophthalmology, Eye & ENT Hospital, Fudan University, Shanghai, China.
NHC Key Laboratory of Myopia (Fudan University), Key Laboratory of Myopia, Chinese Academy of Medical Sciences, Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Institute of Neuroscience and Medicine (INM-1), Forschungszentrum Jülich GmbH, 52425, Jülich, Germany.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Ophthalmology, EYE & ENT Hospital of Fudan University, 19 Baoqing Road, Shanghai, 200031, China.
NHC Key Laboratory of Myopia (Fudan University), Shanghai, China.
Shanghai Research Center of Ophthalmology and Optometry, Shanghai, China.
Shanghai Engineering Research Center of Laser and Autostereoscopic 3D for Vision Care, Shanghai, China.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Eye Center, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China (Q.Z.).
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Physics, University College London, Gower Street, London WC1E 6BT, United Kingdom.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Augusta University, Augusta, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Pharmacology and Toxicology, Augusta University, Augusta, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Department of Neural Sciences, Temple University, Philadelphia, United States.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Publications dans "Neurofibres myélinisées" :
2 publications dans cette catégorie
Affiliations :
Interventional Molecular Imaging Laboratory, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Laboratory of BioNanoTechnology, Wageningen University & Research, Bornse Weilanden 9, 6708 WG Wageningen, The Netherlands.
Publications dans "Neurofibres myélinisées" :
1 publication dans cette catégorie
Affiliations :
Department of Neurology, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074 Aachen, Germany.
Publications dans "Neurofibres myélinisées" :
Age-related macular degeneration (AMD) is one of the leading causes of blindness and can progress to geographic atrophy (GA) in late stages of disease. This review article highlights recent literature...
Technology for diagnosing and monitoring GA has made significant advances in recent years, particularly regarding the use of optical coherence tomography (OCT). Identification of imaging features whic...
Identification of GA and of risk factors for GA development or progression is essential when counseling AMD patients and discussing prognosis. With new therapies on the horizon for the treatment of GA...
Vocal fold atrophy (VFA) is associated with aging and Parkinson's disease (PD). Clinical diagnosis of VFA depends on several visual-perceptual laryngostroboscopy findings that are inherently subjectiv...
Thirty-six patients >60 years of age with VFA were included in this retrospective cohort study. Demographic information, medical history, Consensus Auditory-Perceptual Evaluation of Voice (CAPE-V), Vo...
BI was positively correlated with CAPE-V. Patients with CAPE-V >30 had a significantly larger BI compared to those with CAPE-V <30. Patients with PD had significantly larger BI than those with ARVA. D...
Quantitative measures supported an association between bowing severity and dysphonia severity in patients with PD and ARVA. A PD diagnosis significantly predicted more severe BI. These findings demons...
3 Laryngoscope, 133:1462-1469, 2023....
Vulvovaginal atrophy (VVA) is a chronic and progressive disease that affects sexuality and quality of life. VVA is preventable and treatable, but requires long-term and often sequential treatment. Seq...
To compare clinical and imaging characteristics of extensive macular atrophy with pseudodrusen-like appearance (EMAP) versus diffuse-trickling geographic atrophy (DTGA) and non-diffuse-trickling geogr...
We herein report a 45-year-old man with dentatorubropallidoluysian atrophy (DRPLA) who presented with mild dementia, ataxia, and involuntary movement and developed constipation, dysuria, and orthostat...
Numerous children born with syndromic craniosynostosis will develop visual impairments. Based on the hypothesis that elevations in intracranial pressure might have greater impacts on vision than devel...
The authors conducted a retrospective chart review of all children with syndromic craniosynostosis treated at a single center....
Of 442 patients with syndromic craniosynostosis, complete ophthalmologic records were available for 253. Although no instances of optic nerve atrophy were noted among those with Saethre-Chotzen or Mue...
A substantial percentage of children with Apert, Crouzon, and Pfeiffer syndromes were found to develop optic nerve atrophy, with a prevalence likely to trend higher with longer follow-up. Chiari malfo...
Risk, III....
Posterior cortical atrophy (PCA) is a progressive neurologic syndrome that presents with complex visual deficits. Although PCA is most commonly a form of Alzheimer disease (AD), its early diagnosis is...
To identify neurobehavioral screening tasks for PCA-beyond simple visual constructions-that can be administered in clinic or at bedside....
We compared the performance of 12 individuals who met neuroimaging-supported consensus criteria for PCA with that of 12 matched individuals with typical AD (tAD) and 24 healthy controls (HC) on clinic...
All of the individuals with PCA were impaired on the figure-ground discrimination task compared with half of the tAD group and no HC. Approximately half of the PCA group had Balint syndrome, dressing ...
The figure-ground discrimination task can be used successfully as an overall screening measure for PCA, followed by specific tasks for Balint syndrome and dressing and limb apraxia. Findings reinforce...
To present electroretinogram findings in extensive macular atrophy with pseudodrusen (EMAP) and describe associated systemic factors....
Retrospective case series....
Data on medical history, visual symptoms, multimodal imaging findings, and visual field were collected from the medical records of patients with extensive macular atrophy with pseudodrusen who attende...
Eighteen patients (10 [56%] females, age 49-66 years) were included. Of these, 17 (94%) had a history of rheumatic fever in childhood and/or adolescence, 7 (39%) had cardiovascular disease, 4 (22%) ha...
In this cohort, electrophysiologic evaluation demonstrated diffuse retinal dysfunction affecting all layers of the retina in patients with EMAP. The disease is associated with immune-mediated systemic...
Change in ventricular volume has been suggested as surrogate measure of central brain atrophy (CBA) applicable to the everyday management of multiple sclerosis (MS) patients....
We investigated the contribution of inflammatory activity (including the severity of lesional tissue damage) to CBA....
Fifty patients with relapsing-remitting multiple sclerosis (RRMS) were enrolled. Lesional activity during 4 years of follow-up was analysed using custom-build software, which segmented expanding part ...
During follow-up, ventricles expanded on average by 12.6% ± 13.7% (mean ±...
CBA is almost entirely explained by the combination of the volume and severity of lesional activity. The expansion of chronic lesions plays a central role in this process....
The inositol 1,4,5-triphosphate receptor type 1 (...